Key result
Esmolol infusion reduces aortic remodeling and improves arterial compliance for one month in hypertensive rats.
Why the study?
Short-term esmolol protects against large artery remodeling, but whether this regression of thoracic aorta remodeling persists after treatment withdrawal remains unknown.
Does short-term esmolol treatment improve thoracic aorta remodeling and does the effect persist after withdrawal in spontaneously hypertensive rats?
Does short-term esmolol treatment improve thoracic aorta remodeling and does the effect persist after withdrawal in spontaneously hypertensive rats?
Short-term esmolol treatment induces sustained regression of thoracic aortic remodeling in hypertensive rats that persists up to one month after withdrawal, potentially independent of blood pressure.
Answers are grounded in this paper and cite their sources.
Short-term esmolol may merit human investigation for aortic remodeling; leaves open translation beyond hypertensive rat models.
Background: Our research group has previously demonstrated the protective effect of short-term treatment with esmolol on large artery remodeling. However, whether this beneficial effect persists after treatment withdrawal remains unknown. Therefore, the aim of the present study was to investigate whether regression of thoracic aorta remodeling after a short-term esmolol treatment persists following drug withdrawal. Methods: Adult male spontaneously hypertensive rats (SHRs) received either esmolol (300 µg/kg/min) or vehicle (saline solution) by continuous infusion for 48 h. Following treatment, animals were evaluated either immediately (SHR-E 48 h group) or after withdrawal periods of 7 days (SHR-E 7 d group) or 1 month (SHR-E 1 m group). Hemodynamic parameters, thoracic aorta geometry, extracellular matrix composition (elastin and collagen), and the passive mechanical response of the arterial wall (β parameter) were assessed in all animals. Results: Forty-eight hours of esmolol treatment significantly reduced blood pressure and attenuated thoracic aortic wall thickness, external diameter, cross-sectional area, collagen content and elastic fiber density. Additionally, passive mechanical testing showed a significant reduction in the β parameter, indicating improved arterial compliance after treatment. Remarkably, these structural and mechanical benefits persisted for up to one month after withdrawal, despite the return of blood pressure to hypertensive levels. Conclusions: Protective effect of esmolol on aortic remodeling is persistent after treatment withdrawal in SHRs, perhaps independent of blood pressure.
No takes yet. Share an insight, caveat, or question.
Fernández-Morales et al. (2026) studied Hypertension (n=48). Esmolol vs. Saline solution was evaluated on Thoracic aorta remodeling (geometry, extracellular matrix composition, and passive mechanical response). A 48-hour infusion of esmolol significantly attenuated thoracic aortic remodeling and improved arterial compliance in spontaneously hypertensive rats, with benefits persisting for up to one month.
Synapse has enriched 10 related papers. Consider them for comparative context: